Folic Acid and Ovarian Reserve: More is Not Always Better, Precision Supplementation is Key

For women preparing for pregnancy, ovarian health is the cornerstone of successful conception.

Folic acid, as a "standard nutrient" for pre-pregnancy care, is well-known for its importance in preventing birth defects, reducing the risk of congenital heart disease, and neural tube defects. However, a study published in November 2021 in the authoritative reproductive medicine journal Fertility and Sterility has provided new insights into the relationship between folic acid and ovarian reserve.


Research Findings: A Plateau Effect Exists

This study analyzed data from 552 women who visited the Massachusetts General Hospital Fertility Center in the United States, focusing on the association between folic acid intake and ovarian reserve function (measured by Antral Follicle Count, AFC).


The research revealed an interesting phenomenon: there is a clear dose-response relationship between folic acid intake and ovarian reserve, but this relationship is not linear; instead, it exhibits a plateau effect.

The data indicated that the positive correlation between total folic acid intake and AFC reaches a plateau at approximately 1200 micrograms per day. The peak benefit for folic acid intake from supplements (Folic acid, synthetic folic acid) occurs at about 800 micrograms per day. Compared to women with a daily intake of 400 micrograms of folic acid, those consuming 800 micrograms per day are expected to have an increase of approximately 1.5 follicles.

The study also found that once intake exceeds these levels, higher folic acid consumption does not provide additional benefits. This suggests that while folic acid is important for follicles, supplementation should focus on "precision" rather than "quantity."

How Does Folic Acid "Protect" Follicles?

The active form of folic acid in the body (5-methyltetrahydrofolate) is a key cofactor in the metabolism of homocysteine (Hcy).


When folic acid is insufficient, Hcy cannot be efficiently converted into beneficial methionine, leading to its accumulation in the blood. This results in hyperhomocysteinemia (HHcy), which can affect ovarian health, induce oxidative stress and inflammation, and disrupt the microenvironment required for follicular development.

Simultaneously, folic acid deficiency can impair normal methylation processes, affecting the genetic stability and developmental potential of oocytes.

Therefore, maintaining adequate folic acid levels helps create a more stable and favorable internal environment for follicular development.

Individual Differences: Why Are Some People Less Responsive to Folic Acid Supplementation?

Studies show that approximately 78.4% of the Chinese population has varying degrees of folic acid metabolic impairment, with folic acid metabolic capacity only 30-70% that of individuals with normal metabolism.

MTHFR Genotype

Enzyme Activity

Folic Acid Utilization Capacity

Proportion in Chinese Han Population

Risk of Hyperhomocysteinemia

CC

Normal (100%)

Strong

21.6%

Low

CT

Intermediate (65%)

Moderate

48.6%

Medium

TT

Low (35%)

Poor

29.8%

High

Geographical Distribution of MTHFR C677T, A1298C and MTRR A66G Gene Polymorphisms in China: Findings from 15357 Adults of Han Nationality. PLOS ONE.


For women preparing for pregnancy who have folic acid metabolism disorders, active folate (such as Magnafolate, [6S]-5-methyltetrahydrofolate calcium) is a more efficient choice.

Compared to ordinary synthetic folic acid (Folic acid), active folate (such as Magnafolate) is not limited by folate metabolism genes. It can be directly absorbed by the body, rapidly increasing serum folate and red blood cell folate levels. It participates in the methionine cycle to reduce Hcy levels in the body, providing better folate supplementation.

References

[1] Kadir, M. (2021). Folate Intake and Ovarian Reserve Among Women Attending a Fertility Center [Doctoral dissertation, Emory University]. Emory Theses and Dissertations. [2] Bailey, S. W., & Ayling, J. E. (2018). The pharmacokinetic advantage of 5-methyltetrahydrofolate for minimization of the risk for birth defects. Scientific Reports, 8, 4096. [3] Lian, Z., Liu, K., Gu, J., et al. (2022). Biological characteristics and applications of folic acid and 5-methyltetrahydrofolate. China Food Additives, (2).

This article is for informational purposes only and does not substitute professional medical advice. Please consult a healthcare provider for personalized guidance.


Let's talk

We're Here to Help

Contact Us
 

展开
TOP